Adult attention deficit hyperactivity disorder
| Adult attention deficit hyperactivity disorder | |
|---|---|
| Synonyms | Adult ADHD |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Inattention, hyperactivity, impulsivity |
| Complications | Substance use disorder, relationship issues, occupational difficulties |
| Onset | Childhood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic predisposition, environmental factors |
| Risks | Family history, substance abuse, stress |
| Diagnosis | Clinical assessment, DSM-5 criteria |
| Differential diagnosis | Bipolar disorder, anxiety disorders, depression |
| Prevention | N/A |
| Treatment | Medication, psychotherapy, behavioral therapy |
| Medication | Stimulants, non-stimulants |
| Prognosis | Variable, can be managed with treatment |
| Frequency | 2.5% of adults |
| Deaths | N/A |
Adult Attention Deficit Hyperactivity Disorder (ADHD) is a mental health condition characterized by patterns of inattention, hyperactivity, and impulsivity that are more pronounced than typically observed in individuals at a comparable level of development. While ADHD is often diagnosed in children, it can persist into adulthood and affect an individual's daily life, including their work performance, relationships, and self-esteem.
Symptoms and Diagnosis[edit]
Adult ADHD symptoms can be divided into two main categories: inattention and hyperactivity-impulsivity. Inattention symptoms may include difficulty maintaining focus, following detailed instructions, and organizing tasks. Hyperactivity-impulsivity symptoms can manifest as restlessness, an inability to stay seated, excessive talking, and impulsive decisions without considering the consequences. Diagnosis of ADHD in adults requires a comprehensive evaluation, often including a detailed history of the individual's childhood behavior, academic performance, and a review of symptoms. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria are commonly used to diagnose ADHD. It is important to rule out other conditions that may mimic ADHD or occur as comorbid conditions, such as anxiety disorders, depression, and substance abuse.
Treatment[edit]
Treatment for adult ADHD typically involves a combination of medication, psychotherapy, and lifestyle changes. Stimulant medications, such as methylphenidate and amphetamines, are often effective in managing symptoms. Non-stimulant medications, including atomoxetine and certain antidepressants, may also be used. Psychotherapy, particularly cognitive-behavioral therapy (CBT), can help individuals develop coping strategies and address any co-occurring mental health issues. Lifestyle modifications, such as regular exercise, a healthy diet, and adequate sleep, can further help manage symptoms.
Impact[edit]
Adult ADHD can significantly impact various aspects of life. Individuals may struggle with organizational skills, time management, and maintaining relationships. These challenges can lead to underachievement in the workplace, academic difficulties, and low self-esteem. Recognizing and treating ADHD in adults is crucial for improving quality of life and preventing the long-term consequences of untreated ADHD.
Epidemiology[edit]
The prevalence of ADHD in adults, while difficult to estimate accurately, is thought to be around 2.5% to 4% of the global population. ADHD is more commonly diagnosed in males than females, though this may reflect a bias in diagnosis rather than an actual difference in prevalence.
History[edit]
Historically, ADHD was considered a condition that primarily affected children, with the expectation that they would "outgrow" it. However, research over the past few decades has shown that ADHD can persist into adulthood and that adults can be diagnosed even if they were not diagnosed as children.
See Also[edit]
- Childhood attention deficit hyperactivity disorder
- Cognitive behavioral therapy
- Stimulant medication
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian